Multimodal artificial intelligence model based on CT for differentiating primary renal sarcomas from renal cell carcinomas: a dual-center retrospective study

基于CT的多模态人工智能模型鉴别原发性肾肉瘤与肾细胞癌:一项双中心回顾性研究

阅读:3

Abstract

BACKGROUND: Due to the prognosis and treatment differences between primary renal sarcomas and renal cell carcinoma (RCC), preoperative differentiation between them is important but challenging. This study aims to explore and develop a diagnostic method based on computed tomography (CT) and clinical data for preoperatively differentiating primary renal sarcomas from RCCs. METHODS: Patients pathologically diagnosed with primary renal sarcoma from two centers were retrospectively included, and RCCs were probably 2:1 compared to renal sarcomas as the control group. Clinical data, standard contrast-enhanced CT images and histological findings were obtained. A clinical model was established with independent indicators based on logistic regression analysis. The region of interest was outlined in each of the three modal CT images [unenhanced phase (UP), corticomedullary phase (CMP) and nephrographic phase (NP)] and formed 7 modal imaging datasets for deep learning (DL) models' development. Reported performance metrics included accuracy (ACC) and area under the curve (AUC). RESULTS: Totally, 7,482 images were obtained from 85 patients. Multivariate logistic regression showed that the independent indicators of renal sarcoma were intratumoral arteries and Gerota's fascia invasion (P<0.05). The AUC of clinical model was 0.77 [95% confidence interval (CI): 0.67-0.87], sensitivity 0.74, specificity 0.67, positive predictive value (PPV) 0.51, and negative predictive value (NPV) 0.85. The DL models yielded effective discrimination. The UP model yielded AUC of 0.95±0.09 and ACC of 0.94±0.07, and UP + NP model yielded nearly AUC =0.95±0.06, and ACC =0.94±0.07. CONCLUSIONS: The multimodal artificial intelligence (AI) models show good performance for differentiating renal sarcomas from RCCs, which assist in individualized management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。